Joshua Silva, MD, combines clinical research with years of hands-on experience to create individualized treatment plans grounded in science, not trends
Working with PlexusDx for Comprehensive Medication Management PlexusDx provides access to compounded semaglutide and tirzepatide medications from licensed 503A compounding pharmacies, serving all 50 states without requiring insurance or membership fees
Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial (PubMed PMID 37366315)
These ads are designed so that you can buy a product at a reduced price
Weekly subcutaneous VK2735, a GIP/GLP-1 receptor dual agonist, for weight management: Phase 2, randomized, 13-week VENTURE study
There's another important thing the TGA is worried about: people on compounded weight loss medications may be less likely to report side effects at all